Property | Value |
?:abstract
|
-
One of the objectives that the scientific community is setting itself is to understand whether acquired immunity and the presence of antibodies against acute coronavirus 2 (SARS-CoV-2) antibodies protect against reinfection. Although there are many published papers describing how the re-positivization of nasopharyngeal swab polymerase chain reaction real time (RT-PCR) test and clinical healing of the subject can be justified by numerous reasons and random situations. Our aim is to highlight how there are certain populations more susceptible to re-infection than others. This article is protected by copyright. All rights reserved.
|
is
?:annotates
of
|
|
?:creator
|
|
?:doi
|
|
?:doi
|
|
?:journal
|
|
?:license
|
|
?:pdf_json_files
|
-
document_parses/pdf_json/2636365763222f4834438494abe0af57753ebc2c.json
|
?:pmc_json_files
|
-
document_parses/pmc_json/PMC7753699.xml.json
|
?:pmcid
|
|
?:pmid
|
|
?:pmid
|
|
?:publication_isRelatedTo_Disease
|
|
is
?:relation_isRelatedTo_publication
of
|
|
?:sha_id
|
|
?:source
|
|
?:title
|
-
Recurrent COVID‐19 pneumonia in the course of chemotherapy: Consequence of a weakened immune system?
|
?:type
|
|
?:year
|
|